` ME1 (Melodiol Global Health Ltd) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

ME1
vs
NOVO B

Over the past 12 months, ME1 has underperformed NOVO B, delivering a return of -80% compared to the NOVO B's 56% drop.

Valuation Comparison

ME1 Intrinsic Value
Not Available
NOVO B Intrinsic Value
625.37 DKK
Undervaluation 27%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Melodiol Global Health Ltd
ASX:ME1
0.001 AUD
Novo Nordisk A/S
CSE:NOVO B
456.65 DKK

Financials Comparison

Growth Over Time
ME1 vs NOVO B

ME1
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Melodiol Global Health Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ME1 vs NOVO B

ME1
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Melodiol Global Health Ltd
ASX:ME1
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

ME1
15.4%
NOVO B
84.3%

Operating Margin

ME1
-83%
NOVO B
44.6%

Net Margin

ME1
-267.6%
NOVO B
34.5%

FCF Margin

ME1
-43.1%
NOVO B
24.5%

ROE

ME1
-575.3%
NOVO B
88.1%

ROA

ME1
-183.9%
NOVO B
26.6%

ROIC

ME1
-113.5%
NOVO B
30.4%

ROCE

ME1
-177.7%
NOVO B
70%

Stocks Performance

Stocks Performance
ME1 vs NOVO B

Loading

Performance Gap
ME1 vs NOVO B

Loading
ME1
NOVO B
Difference
www.alphaspread.com

Performance By Year
ME1 vs NOVO B

Loading
ME1
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account